Multibagger in just 1 month: Keep an eye on this stock, which was locked in the upper circuit on February 07
The stock gave multibagger returns of 141.35 per cent in just 1 month whereas BSE Small-cap Index is down by 3.36 per cent.
One of the gainers on BSE today, shares of Shukra Pharmaceuticals Ltd soared 5 per cent upper circuit to Rs 66.30 per share. The stock also traded at a new 52-week high of Rs 66.30.
The company recently issued rights on Thursday, February 02, 2023 for its existing shareholders of the company. Today, shares of the firm saw a spurt in volume by more than 1.38 times on BSE.
Shukra Pharmaceuticals Ltd, founded in 1993, is a Small-Cap company (having a market cap of Rs 50 crore). It is involved in the production and sale of pharmaceutical products, as well as laboratory testing.
In its quarterly and annual financial statements, the corporation achieved successful outcomes. Comparing Q2FY22 to Q2FY23, net sales increased by 24.83 per cent, while net profit increased by 300 per cent. The company generated net sales of Rs 20.48 crore in FY22 and net profit soared by 295 per cent compared to FY21. The stock has a 1-year CAGR of 356 per cent.
The stock had successive upward circuits and 52-week highs in recent trading sessions. The stock gave multibagger returns of 141.35 per cent in just 1 month whereas BSE Small-cap Index is down by 3.36 per cent. Investors should keep an eye on this multibagger stock.